|
|||||
|
|
||||||
Originally published as JCO Early Release 10.1200/JCO.2005.11.136 on March 21 2005 © 2005 American Society of Clinical Oncology. Improved Detection of Prostate Cancer Using Classification and Regression Tree AnalysisFrom the Division of Urology, Portland Veterans Administration Medical Center; Divisions of Urology and Hematology and Medical Oncology, Oregon Health and Science University; and Biostatistics Shared Resource, Oregon Health and Science University Cancer Institute, Portland, OR Address reprint requests to Mark Garzotto, MD, Urology Section, Portland Veterans Administration Medical Center, 3710 SW US Veterans Hospital Rd, Portland, OR 97239; e-mail: garzotto{at}ohsu.edu PURPOSE: To build a decision tree for patients suspected of having prostate cancer using classification and regression tree (CART) analysis.
PATIENTS AND METHODS: Data were uniformly collected on 1,433 referred men with a serum prostate-specific antigen (PSA) levels of
RESULTS: CART analysis selected a PSA cutoff of more than 1.55 ng/mL for further work-up, regardless of DRE findings. CART then selected the following subgroups at risk for a positive biopsy: (1) PSAD more than 0.165 ng/mL/cc; (2) PSAD CONCLUSION: Application of CART analysis to the prostate biopsy decision results in a significant reduction in unnecessary biopsies while retaining a high degree of sensitivity when compared with the standard of performing a biopsy of all patients with an abnormal PSA or DRE. Supported by Veterans Affairs Career Development Award (M.G.) and National Institutes of Health grant No. P30 CA 69533 to the Biostatistics Shared Resource of the Oregon Health and Science University Cancer Institute. Authors' disclosures of potential conflicts of interest are found at the end of this article.
Related Editorial
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|